Monopar Therapeutics Inc. (MNPR)
Market Closed
1 Sep, 20:00
$
117. 57
+5.64
+5.0389%
After Hours
$
+12.81 +10.8956% 130. 38
749.56M Market Cap
- P/E Ratio
- Div Yield
95,170 Volume
-0.65 Eps
$ 111.93
Previous Close 
Want to track MNPR and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Monopar Therapeutics Inc. (MNPR) Statistics
Valuation metrics
Market Cap 749.56M
Enterprise value 696.91M
Trailing P/E (ttm) -47.82
Forward P/E -14.52
PEG ratio 1.67
Price/Sales (ttm) -
Price/Book (mrq) 7.3
Enterprise Value/Revenue -
Enterprise Value/EBITDA -37.67
Overview
Shares outstanding 6.69M
Float 4.4M
Shares short 1.68M
% Held by insiders 0.24%
% Held by institutions 0.83%
Average volume (10 days) 221.54K
Average volume (90 days) 275.88K
Price summary
52-Week low 32.77
52-Week high 124.82
Beta 1.66
50-Day moving average 110.24
200-Day moving average 63.1
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:5
Last split Date 13 Aug 2024
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.13%
Return on equity -0.13%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -13.72M
Diluted EPS (ttm) -2.09
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) 140.4M
Total cash per share (mrq) 15.72
Total debt (mrq) 245.49K
Total Debt/Equity (mrq) 0
Current ratio (mrq) 33.56%
Book value per share (mrq) 15.32
Cash Flow
Cash flow statement -12.2M
Levered free cash flow (LFCF) -8.2M
